Exact Inference about the Within-Subject Variability in 2 × 2 Crossover Trials
2×2交叉试验中个体内变异的精确推断AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要讨论交叉试验中的方差与均值推断,未明确给出所列因果推断或面板计量框架。
2×2交叉试验中个体内变异的精确推断AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
The comparison of primary interest in a 2 × 2 crossover trial typically concerns the effect of the treatments, say A and B, on the mean response level. This article deals with another important aspect, namely the within-subject response variability under A and B. Differences in drug formulation and/or administration may lead to considerable differences in within-subject variability, whatever the difference in terms of mean level. Consideration of both these aspects may, therefore, be of considerable importance for the judgement of the treatments. It is shown that although there are no within-subject treatment replications, it is possible to make various exact inferences about the A/B ratio of within-subject variances and about the (A – B)-difference in mean level, simultaneously and marginally. These inferences are semiparametric in that no distributional assumption is made about the between-subject variability, whereas a normality assumption is used for the within-subject variability. The inferences include tests, confidence regions, and a multiple test procedure. A power approximation is also given. The results are illustrated numerically.